Clinical Trial: Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma

U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099547) titled 'Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma' on July 25.

Brief Summary: This is a randomized, open-label, phase II study evaluating first-line treatment for advanced gallbladder cancer. It aims to assess the efficacy, safety, pharmacokinetics, and immunogenicity of the ZG005 in Combination with gemcitabine and cisplatin as first-line therapy in Participants with advanced gallbladder cancer.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Biliary Tract Carcinoma

Intervention: DRUG: ZG005

ZG005 20 mg/kg IV Q3W

DRUG: Tislelizumab

Tislel...